{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:13:17Z","timestamp":1793653997403,"version":"4.5.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0026114"],"award-info":[{"award-number":["NNF17OC0026114"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R238-2016-2859)"],"award-info":[{"award-number":["R238-2016-2859)"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psilocybin and other serotonergic psychedelics have re-emerged as therapeutics for neuropsychiatric disorders, including addiction. Psilocybin induces long-lasting effects on behavior, likely due to its profound ability to alter consciousness and augment neural connectivity and plasticity. Impaired synaptic plasticity in obesity contributes to \u2018addictive-like\u2019 behaviors, including heightened motivation for palatable food, and excessive food seeking and consumption. Here, we evaluate the effects of psilocybin on feeding behavior, energy metabolism, and as a weight-lowering agent in mice. We demonstrate that a single dose of psilocybin substantially alters the prefrontal cortex transcriptome but has no acute or long-lasting effects on food intake or body weight in diet-induced obese mice or in genetic mouse models of obesity. Similarly, sub-chronic microdosing of psilocybin has no metabolic effects in obese mice and psilocybin does not augment glucagon-like peptide-1 (GLP-1) induced weight loss or enhance diet-induced weight loss. A single high dose of psilocybin reduces sucrose preference but fails to counter binge-like eating behavior. Although these preclinical data discourage clinical investigation, there may be nuances in the mode of action of psychedelic drugs that are difficult to capture in rodent models, and thus require human evaluation to uncover.<\/jats:p>","DOI":"10.1038\/s41398-022-02103-9","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T03:02:59Z","timestamp":1660186979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Nicole","family":"Fadahunsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-6033","authenticated-orcid":false,"given":"Jens","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberte Wollesen","family":"Breum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie Vad","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Beck","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6866","authenticated-orcid":false,"given":"Gitte Moos","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Bue","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-9667","authenticated-orcid":false,"given":"Christoffer","family":"Clemmensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2103_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1467-789X.2012.01031.x","volume":"14","author":"ND Volkow","year":"2013","unstructured":"Volkow ND, Wang G-J, Tomasi D, Baler RD. Obesity and addiction: neurobiological overlaps. Obes Rev. 2013;14:2\u201318.","journal-title":"Obes Rev"},{"key":"2103_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nn1452","volume":"8","author":"ND Volkow","year":"2005","unstructured":"Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555\u201360. 2005 85.","journal-title":"Nat Neurosci"},{"key":"2103_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/nyas.13665","volume":"1428","author":"BA Matikainen-Ankney","year":"2018","unstructured":"Matikainen-Ankney BA, Kravitz AV. Persistent effects of obesity: a neuroplasticity hypothesis. Ann NY Acad Sci. 2018;1428:221\u201339.","journal-title":"Ann NY Acad Sci"},{"key":"2103_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuropharm.2004.06.025","volume":"47","author":"TE Robinson","year":"2004","unstructured":"Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004;47:33\u201346.","journal-title":"Neuropharmacology"},{"key":"2103_CR5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/npp.2016.284","volume":"42","author":"JL Thompson","year":"2017","unstructured":"Thompson JL, Drysdale M, Baimel C, Kaur M, MacGowan T, Pitman KA, et al. Obesity-induced structural and neuronal plasticity in the lateral orbitofrontal cortex. Neuropsychopharmacol. 2017;42:1480\u201390. 2017 427.","journal-title":"Neuropsychopharmacol"},{"key":"2103_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197\u2013206.","journal-title":"Nature"},{"key":"2103_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","volume":"181","author":"D Nutt","year":"2020","unstructured":"Nutt D, Erritzoe D, Carhart-Harris R. Psychedelic psychiatry\u2019s brave new world. Cell. 2020;181:24\u20138.","journal-title":"Cell"},{"key":"2103_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenb\u00e6k DS, Kristiansen S, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacol. 2019;44:1328\u201334. 2019 447.","journal-title":"Neuropsychopharmacol"},{"key":"2103_CR9","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170.","journal-title":"Cell Rep"},{"key":"2103_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 2018;235:399\u2013408.","journal-title":"Psychopharmacology"},{"key":"2103_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355.","journal-title":"Annu Rev Med"},{"key":"2103_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","volume":"51","author":"LK Heisler","year":"2006","unstructured":"Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006;51:239\u201349.","journal-title":"Neuron"},{"key":"2103_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroimage.2009.01.050","volume":"46","author":"D Erritzoe","year":"2009","unstructured":"Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage. 2009;46:23\u201330.","journal-title":"Neuroimage"},{"key":"2103_CR14","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.1523\/JNEUROSCI.3348-14.2015","volume":"35","author":"ME Haahr","year":"2015","unstructured":"Haahr ME, Hansen DL, Fisher PM, Svarer C, Stenb\u00e6k DS, Madsen K, et al. Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals. J Neurosci. 2015;35:5884\u20139.","journal-title":"J Neurosci"},{"key":"2103_CR15","doi-asserted-by":"publisher","first-page":"e13210","DOI":"10.1111\/obr.13210","volume":"22","author":"KA Galen","year":"2021","unstructured":"Galen KA, van, Horst KW, ter, Serlie MJ. Serotonin, food intake, and obesity. Obes Rev. 2021;22:e13210.","journal-title":"Obes Rev"},{"key":"2103_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0091-3057(86)90467-3","volume":"24","author":"PJ Fletcher","year":"1986","unstructured":"Fletcher PJ, Burton MJ. Microstructural analysis of the anorectic action of peripherally administered 5-HT. Pharm Biochem Behav. 1986;24:1133\u20136.","journal-title":"Pharm Biochem Behav"},{"key":"2103_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1210\/en.2007-1321","volume":"149","author":"DD Lam","year":"2008","unstructured":"Lam DD, Przydzial MJ, Ridley SH, Yeo GSH, Rochford JJ, O\u2019Rahilly S, et al. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology. 2008;149:1323\u20138.","journal-title":"Endocrinology"},{"key":"2103_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.metabol.2017.09.007","volume":"85","author":"KA Galen","year":"2018","unstructured":"Galen KA, van, Horst KW, ter, Booij J, Fleur SE, la, Serlie MJ. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metab - Clin Exp. 2018;85:325\u201339.","journal-title":"Metab - Clin Exp"},{"key":"2103_CR19","unstructured":"Tilson HA, Marquis WJ, Rech RH. Effects of d-aphetamine, 2,5-dimethoxy-4-methylamphetamine (DOM), and psilocybin on fixed-interval responding in the rat Proc. Am. Psychol. Ass. (1973)."},{"key":"2103_CR20","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/0024-3205(79)90451-X","volume":"24","author":"DB Vaupel","year":"1979","unstructured":"Vaupel DB, Nozaki M, Martin WR, Bright LD, Morton EC. The inhibition of food intake in the dog by LSD, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives. Life Sci. 1979;24:2427\u201331.","journal-title":"Life Sci"},{"key":"2103_CR21","doi-asserted-by":"crossref","unstructured":"Flanagan TW, Sebastian MN, Battaglia DM, Foster TP, Maillet EL, Nichols CD. Activation of 5-HT 2 receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice. Sci Rep 2019;9:13444.","DOI":"10.1038\/s41598-019-49987-0"},{"key":"2103_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0269881121996863","volume":"35","author":"O Simonsson","year":"2021","unstructured":"Simonsson O, Sexton JD, Hendricks PS. Associations between lifetime classic psychedelic use and markers of physical health. J Psychopharmacol. 2021;35:447\u201352.","journal-title":"J Psychopharmacol"},{"key":"2103_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00401509","volume":"11","author":"SJ Corne","year":"1967","unstructured":"Corne SJ, Pickering RW. A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacol. 1967;11:65\u201378.","journal-title":"Psychopharmacol"},{"key":"2103_CR24","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/oby.2010.46","volume":"18","author":"TA Czyzyk","year":"2010","unstructured":"Czyzyk TA, Sahr AE, Statnick MA. A model of binge-like eating behavior in mice that does not require food deprivation or stress. Obesity (Silver Spring). 2010;18:1710\u20131717.","journal-title":"Obesity (Silver Spring)"},{"key":"2103_CR25","doi-asserted-by":"crossref","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. Sequence analysis STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15\u201321.","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2103_CR26","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish A, Diekhans M, Ferreira AM, Johnson R, Jungreis I, Loveland J, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47:D766\u201373.","journal-title":"Nucleic Acids Res"},{"key":"2103_CR27","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;41:e108\u2013e108.","journal-title":"Nucleic Acids Res"},{"key":"2103_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"2103_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:1\u201317.","journal-title":"Genome Biol"},{"key":"2103_CR30","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47\u2013e47.","journal-title":"Nucleic Acids Res"},{"key":"2103_CR31","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gks461","volume":"40","author":"D Wu","year":"2012","unstructured":"Wu D, Smyth GK. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 2012;40:e133\u2013e133.","journal-title":"Nucleic Acids Res"},{"key":"2103_CR32","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"2103_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/0269881110388326","volume":"25","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Koedood L, Powell SB, Geyer MA. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol. 2011;25:1548\u201361.","journal-title":"J Psychopharmacol"},{"key":"2103_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharm. 2003;463:3\u201333.","journal-title":"Eur J Pharm"},{"key":"2103_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0269881120959614","volume":"35","author":"OH Jefsen","year":"2021","unstructured":"Jefsen OH, Elfving B, Wegener G, M\u00fcller HK. Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin. J Psychopharmacol. 2021;35:483\u201393.","journal-title":"J Psychopharmacol"},{"key":"2103_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881119845793","volume":"33","author":"A Garcia-Romeu","year":"2019","unstructured":"Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. J Psychopharmacol. 2019;33:1088\u2013101.","journal-title":"J Psychopharmacol"},{"key":"2103_CR37","first-page":"379","volume":"7","author":"L Robert","year":"1961","unstructured":"Robert L, Collins BD, Mark Ordy DJ, Thaddeus Samorajski D. Psilocin effects on behaviour and brain serotonin in mice. Trans Assoc Am Physicians. 1961;7:379.","journal-title":"Trans Assoc Am Physicians"},{"key":"2103_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. Acute psychological and physiological affects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology (Berlin). 2004;172:145\u201356.","journal-title":"Psychopharmacology (Berlin)"},{"key":"2103_CR39","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.1971.03190110067020","volume":"217","author":"SA Friedman","year":"1971","unstructured":"Friedman SA, Hirsch SE. Extreme hyperthermia after LSD ingestion. JAMA. 1971;217:1549\u201350.","journal-title":"JAMA"},{"key":"2103_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0010-440X(64)80030-4","volume":"5","author":"LE Hollister","year":"1964","unstructured":"Hollister LE, Sjoberg BM. Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin and a combination of the three psychotomimetic drugs. Compr Psychiatry. 1964;5:170\u20138.","journal-title":"Compr Psychiatry"},{"key":"2103_CR41","doi-asserted-by":"crossref","unstructured":"Flanagan TW, Sebastian MN, Battaglia DM, Foster TP, Maillet EL, Nichols CD. Activation of 5-HT2 receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice. Sci Rep 2019;9.","DOI":"10.1038\/s41598-019-49987-0"},{"key":"2103_CR42","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","volume":"78","author":"Y Schmid","year":"2015","unstructured":"Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, et al. Acute effects of lysergic acid diethylamide in healthy subjects. Biol Psychiatry. 2015;78:544\u201353.","journal-title":"Biol Psychiatry"},{"key":"2103_CR43","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","volume":"334","author":"B Guy-Grand","year":"1989","unstructured":"Guy-Grand B, Crepaldi G, Vre PL, Apfelbaum M, Gries A, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet. 1989;334:1142\u20135.","journal-title":"Lancet"},{"key":"2103_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-009-1694-1","volume":"212","author":"MA Fox","year":"2010","unstructured":"Fox MA, French HT, Laporte JL, Blackler AR, Murphy DL. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology (Berlin). 2010;212:13\u201323.","journal-title":"Psychopharmacology (Berlin)"},{"key":"2103_CR45","doi-asserted-by":"crossref","unstructured":"Aulakh CS, Mazzola-Pomietto P, Hulihan-Giblin BA, Murphy DL. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and S-HT2c receptors, respectively. Neuropsychopharmacology 1995;13:1\u20138","DOI":"10.1038\/sj.npp.1380270"},{"key":"2103_CR46","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2337\/db16-0755","volume":"66","author":"RH Anderberg","year":"2017","unstructured":"Anderberg RH, Richard JE, Eerola K, L\u00f3pez-Ferreras L, Banke E, Hansson C, et al. Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes. 2017;66:1062\u201373.","journal-title":"Diabetes"},{"key":"2103_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1126\/science.7624776","volume":"269","author":"MA Pelleymounter","year":"1995","unstructured":"Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob\/ob mice. Science (80-). 1995;269:540\u20133.","journal-title":"Science (80-)"},{"key":"2103_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0169-328X(00)00167-4","volume":"81","author":"M Collin","year":"2000","unstructured":"Collin M, H\u00e5kansson-Ovesj\u00f6 ML, Misane I, \u00d6gren SO, Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob\/ob mouse. Mol Brain Res. 2000;81:51\u201361.","journal-title":"Mol Brain Res"},{"key":"2103_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0091-3057(94)90423-5","volume":"49","author":"NE Rowland","year":"1994","unstructured":"Rowland NE. Long-term administration of dexfenfluramine to genetically obese (ob\/ob) and lean mice: body weight and brain serotonin changes. Pharm Biochem Behav. 1994;49:287\u201394.","journal-title":"Pharm Biochem Behav"},{"key":"2103_CR50","doi-asserted-by":"crossref","unstructured":"Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams L-A, Hui K, et al. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology (Berlin) 2019;236:731\u201340.","DOI":"10.1007\/s00213-018-5106-2"},{"key":"2103_CR51","first-page":"39","volume":"35","author":"PG Johnstad","year":"2018","unstructured":"Johnstad PG. Powerful substances in tiny amounts: an interview study of psychedelic microdosing. Nordisk Alkohol Nark. 2018;35:39\u201351.","journal-title":"Nordisk Alkohol Nark"},{"key":"2103_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01706-y","volume":"11","author":"MK Doss","year":"2021","unstructured":"Doss MK, Pova\u017ean M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11:1\u201310. 2021 111.","journal-title":"Transl Psychiatry"},{"key":"2103_CR53","doi-asserted-by":"crossref","unstructured":"Nonogaki K, Kaji T. Liraglutide, a GLP-1 receptor agonist, which decreases hypothalamic 5-HT2A receptor expression, reduces appetite and body weight independently of serotonin synthesis in mice. J Diab Res 2018;2018.","DOI":"10.1155\/2018\/6482958"},{"key":"2103_CR54","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014;28:983\u201392.","journal-title":"J Psychopharmacol"},{"key":"2103_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa P, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29:289\u201399.","journal-title":"J Psychopharmacol"},{"key":"2103_CR56","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","volume":"45","author":"MW Meinhardt","year":"2020","unstructured":"Meinhardt MW, G\u00fcng\u00f6r C, Skorodumov I, Mertens LJ, Spanagel R. Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. Neuropsychopharmacol. 2020;45:1316\u201322. 2020 458.","journal-title":"Neuropsychopharmacol"},{"key":"2103_CR57","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1126\/sciadv.abh2399","volume":"7","author":"MW Meinhardt","year":"2021","unstructured":"Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, et al. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv. 2021;7:2399.","journal-title":"Sci Adv"},{"key":"2103_CR58","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/oby.2010.46","volume":"18","author":"TA Czyzyk","year":"2010","unstructured":"Czyzyk TA, Sahr AE, Statnick MA. A model of binge-like eating behavior in mice that does not require food deprivation or stress. Obesity. 2010;18:1710\u20137.","journal-title":"Obesity"},{"key":"2103_CR59","doi-asserted-by":"publisher","first-page":"R814","DOI":"10.1152\/ajpregu.2001.280.3.R814","volume":"280","author":"MM Hagan","year":"2001","unstructured":"Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ. Opioid receptor involvement in the effect of AgRP- (83\u2013132) on food intake and food selection. Am J Physiol Integr Comp Physiol. 2001;280:R814\u201321.","journal-title":"Am J Physiol Integr Comp Physiol"},{"key":"2103_CR60","doi-asserted-by":"crossref","unstructured":"Liu Y, Yin C-Y, Zhu L-J, Zhu X-H, Xu C, Luo C-X, et al Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc n.d.; 2018;13:1686\u20131698.","DOI":"10.1038\/s41596-018-0011-z"},{"key":"2103_CR61","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"L-X Shao","year":"2021","unstructured":"Shao L-X, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron. 2021;109:2535\u201344.e4.","journal-title":"Neuron"},{"key":"2103_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01509-1","volume":"11","author":"K Ilic","year":"2021","unstructured":"Ilic K, Mlinac-Jerkovic K, Sedmak G, Rosenzweig I, Kalanj-Bognar S. Neuroplastin in human cognition: review of literature and future perspectives. Transl Psychiatry. 2021;11:1\u20138. 2021 111.","journal-title":"Transl Psychiatry"},{"key":"2103_CR63","doi-asserted-by":"publisher","first-page":"14265","DOI":"10.1523\/JNEUROSCI.3308-07.2007","volume":"27","author":"TJ Unger","year":"2007","unstructured":"Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci. 2007;27:14265\u201374.","journal-title":"J Neurosci"},{"key":"2103_CR64","doi-asserted-by":"publisher","first-page":"e12083","DOI":"10.14814\/phy2.12083","volume":"2","author":"AJ Boender","year":"2014","unstructured":"Boender AJ, van Gestel MA, Garnerv KM, Luijendijk MCM, Adan RAH. The obesity-associated gene Negr1 regulates aspects of energy balance in rat hypothalamic areas. Physiol Rep. 2014;2:e12083.","journal-title":"Physiol Rep"},{"key":"2103_CR65","first-page":"401","volume":"9","author":"MS Martin-Gronert","year":"2016","unstructured":"Martin-Gronert MS, Stocker CJ, Wargent ET, Cripps RL, Garfield AS, Jovanovic Z, et al. 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. Dis Model Mech. 2016;9:401.","journal-title":"Dis Model Mech"},{"key":"2103_CR66","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S2213-8587(15)00009-1","volume":"3","author":"CN Ochner","year":"2015","unstructured":"Ochner CN, Tsai AG, Kushner RF, Wadden TA. Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations. Lancet Diabetes Endocrinol. 2015;3:232\u20134.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2103_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.physbeh.2013.07.009","volume":"120","author":"CN Ochner","year":"2013","unstructured":"Ochner CN, Barrios DM, Lee CD, Pi-Sunyer FX. Biological mechanisms that promote weight regain following weight loss in obese humans. Physiol Behav. 2013;120:106\u201313.","journal-title":"Physiol Behav"},{"key":"2103_CR68","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs. placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 Randomized Clinical Trial. JAMA. 2021;325:1414\u201325.","journal-title":"JAMA"},{"key":"2103_CR69","first-page":"1","volume":"2021","author":"TD M\u00fcller","year":"2021","unstructured":"M\u00fcller TD, Bl\u00fcher M, Tsch\u00f6p MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2021;2021:1\u201323.","journal-title":"Nat Rev Drug Discov"},{"key":"2103_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abus. 2017;43:55.","journal-title":"Am J Drug Alcohol Abus"},{"key":"2103_CR71","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/acer.13431","volume":"41","author":"AP Le Berre","year":"2017","unstructured":"Le Berre AP, Fama R, Sullivan EV. Executive functions, memory, and social cognitive deficits and recovery in chronic alcoholism: a critical review to inform future research. Alcohol Clin Exp Res. 2017;41:1432.","journal-title":"Alcohol Clin Exp Res"},{"key":"2103_CR72","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1038\/s41366-021-00929-9","volume":"45","author":"J Zhao","year":"2021","unstructured":"Zhao J, Manza P, Gu J, Song H, Zhuang P, Shi F, et al. Contrasting dorsal caudate functional connectivity patterns between frontal and temporal cortex with BMI increase: link to cognitive flexibility. Int J Obes. 2021;45:2608\u201316. 2021 4512.","journal-title":"Int J Obes"},{"key":"2103_CR73","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40519-016-0331-3","volume":"22","author":"C Perpi\u00f1\u00e1","year":"2017","unstructured":"Perpi\u00f1\u00e1 C, Segura M, S\u00e1nchez-Reales S. Cognitive flexibility and decision-making in eating disorders and obesity. Eat Weight Disord. 2017;22:435\u201344.","journal-title":"Eat Weight Disord"},{"key":"2103_CR74","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3389\/fpsyt.2021.735523","volume":"12","author":"MJ Spriggs","year":"2021","unstructured":"Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalh\u00e3es FJC, et al. Study protocol for \u201cpsilocybin as a treatment for anorexia nervosa: a Pilot Study. Front Psychiatry. 2021;12:1770.","journal-title":"Front Psychiatry"},{"key":"2103_CR75","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.brainres.2004.05.093","volume":"1018","author":"XF Huang","year":"2004","unstructured":"Huang XF, Huang X, Han M, Chen F, Storlien L, Lawrence AJ. 5-HT2A\/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Res. 2004;1018:227\u201335.","journal-title":"Brain Res"},{"key":"2103_CR76","first-page":"3227","volume":"18","author":"R Chen","year":"2017","unstructured":"Chen R, Wu X, Jiang L, Zhang Correspondence Y. Single-cell RNA-Seq reveals hypothalamic cell diversity. CellReports. 2017;18:3227\u201341.","journal-title":"CellReports"},{"key":"2103_CR77","doi-asserted-by":"crossref","unstructured":"Gluck ME, Viswanath P, Stinson EJ. Obesity, appetite, and the prefrontal cortex. Curr Obes Rep 2017;6:380\u2013388.","DOI":"10.1007\/s13679-017-0289-0"}],"updated-by":[{"DOI":"10.1038\/s41398-025-03729-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000}}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02103-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:03:02Z","timestamp":1762502582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02103-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02103-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"20 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the originally published version of this article, Figure 4 contained an error in the RNA-seq analysis. During data processing, the subtraction order for the treatment groups was inadvertently reversed (vehicle was subtracted from psilocybin-treated samples, rather than psilocybin-treated minus vehicle). This affected the plotted log fold-change values but does not alter the interpretation of the results, which were discussed only in general terms, nor does it impact the manuscript\u2019s conclusions. The corrected Figure 4 is shown below, and the associated online analysis code has been updated accordingly. The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41398-025-03729-1","URL":"https:\/\/doi.org\/10.1038\/s41398-025-03729-1","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}